CTRI/2019/02/017398
Completed
N/A
A study to evaluate adverse drug reactions and quality of life in HIV/AIDS patients at ART center of Rajindra hospital, Patiala.
Dr Ruchika Irene Dillu0 sites100 target enrollmentTBD
ConditionsHealth Condition 1: null- HIV positive
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- HIV positive
- Sponsor
- Dr Ruchika Irene Dillu
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Diagnosed cases of HIV on ART, being treated on OPD basis.
- •2\. Patient willing to participate in the study and give written informed consent after having been explained about the nature of the study
Exclusion Criteria
- •1\.Patient having known hypersensitivity to any ART drug.
- •2\.Patient not willing to participate in the study after having been explained about the nature of the study.
- •3\.Seriously ill patients
- •4\.CD4 count below 200µl/mm3 i.e., Stage 3 and stage 4 patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Assessment of Adverse drug reactions, drug-drug Interactions and medication adherence outcomes among elderly HIV seropositive patients in comparison with young HIV seropositive patients undergoing highly active antiretroviral therapy.Health Condition 1: null- HIV seropositive patientsCTRI/2018/01/011169Kasturba medical college Kasturba Hospital
Active, Not Recruiting
Phase 1
A Prospective Study to Determine the Adverse Drug Reactions Profile of Anticonvulsants in Children - A Study of Adverse Drug Reactions to Anticonvulsants in ChildreEUCTR2007-000565-37-GBniversity of Nottingham300
Not Yet Recruiting
N/A
Profile of adverse drug reaction in children suffering from cancer in a hospital settingCTRI/2023/11/059711Government Medical College Jammu
Not Yet Recruiting
N/A
A study to capture the side effects and Quality of life(QoL) in castration-resistant prostate cancer patients who are receiving docetaxel as part of standard therapy in Tata Memorial Centre.Health Condition 1: C61- Malignant neoplasm of prostateCTRI/2019/09/021080Tata Memorial Centre
Recruiting
N/A
Evaluation of Adverse Drug Reactions in patients receiving Antiretroviral TherapyHealth Condition 1: B20- Human immunodeficiency virus [HIV]diseaseCTRI/2024/05/067521Government Medical College